期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Development of stimuli responsive polymeric nanomedicines modulating tumor microenvironment for improved cancer therapy
1
作者 Yuanzhen Su guanyu jin +6 位作者 Huicong Zhou Zhaofan Yang Lanqing Wang Zi Mei Qionghua jin Shixian Lv Xuesi Chen 《Medical Review》 2023年第1期4-30,共27页
The complexity of the tumor microenvironment(TME)severely hinders the therapeutic effects of various cancer treatment modalities.The TME differs from normal tissues owing to the presence of hypoxia,lowpH,and immunesup... The complexity of the tumor microenvironment(TME)severely hinders the therapeutic effects of various cancer treatment modalities.The TME differs from normal tissues owing to the presence of hypoxia,lowpH,and immunesuppressive characteristics.Modulation of the TME to reverse tumor growth equilibrium is considered an effective way to treat tumors.Recently,polymeric nanomedicines have been widely used in cancer therapy,because their synthesis can be controlled and they are highly modifiable,and have demonstrated great potential to remodel the TME.In this review,we outline the application of various stimuli responsive polymeric nanomedicines to modulate the TME,aiming to provide insights for the design of the next generation of polymeric nanomedicines and promote the development of polymeric nanomedicines for cancer therapy. 展开更多
关键词 cancer therapy polymeric nanomedicines stimuli responsive tumor microenvironment
原文传递
In situ sustained release hydrogel system delivering GLUT1 inhibitor and chemo-drug for cancer post-surgical treatment
2
作者 Lanqing Wang Zi Mei +5 位作者 guanyu jin Hao Liu Shixian Lv Runjia Fu Muxing Li Cuiping Yao 《Bioactive Materials》 SCIE 2024年第6期541-550,共10页
Systematic administration of small molecular drugs often suffered from the low efficacy and systemic toxicity in cancer therapy.In addition,application of single mode drug usually leads to unsatisfactory therapeutic o... Systematic administration of small molecular drugs often suffered from the low efficacy and systemic toxicity in cancer therapy.In addition,application of single mode drug usually leads to unsatisfactory therapeutic out-comes.Currently,developing multimodal-drug combination strategy that acts on different pathways without increasing side effects remains great challenge.Here,we developed a hydrogel system that co-delivered glycolysis inhibitor apigenin and chemo-drug gemcitabine to realize combination strategy for combating can-cer with minimal systemic toxicity.We demonstrated that this system can not only eliminate tumor cells in situ,but also induce abscopal effect on various tumor models.These results showed that our study provided a safe and effective strategy for clinical cancer treatment. 展开更多
关键词 Chitosan-based hydrogel Drug delivery Controlled-release Abscopal effect Polymer carriers
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部